drugset / Trial / NCT00863317

Trial of Montelukast for Treatment of Acute Bronchiolitis

NCT00863317

Completed 141 enrolled Medical College of Wisconsin
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary rationale for this study is to evaluate the effect of once daily montelukast on duration of acute illness in infants with first-time bronchiolitis.

Timeline

Start
2008-12
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg Oral

Indications